Xeljanz 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

xeljanz

pfizer europe ma eeig - Тофацитиниб - artritis, reumatoidni - imunosupresivi - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 i 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Dengvaxia 欧盟 - 克罗地亚文 - EMA (European Medicines Agency)

dengvaxia

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - denga - cjepiva - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 i 4. korištenje dengvaxia moraju biti u skladu sa službenim preporukama.

anti-Thyroid Transcripton Factor-1 (SP141) 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

anti-thyroid transcripton factor-1 (sp141)

roche d.o.o. ulica grada vukovara 269 a 10000 zagreb -

BOVILIS BOVIPAST RSP 克罗地亚 - 克罗地亚文 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

bovilis bovipast rsp

intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb, hrvatska - inaktivirani goveđi respiratorni sincicijski virus (brsv), soj ev908; inaktivirani virus parainfluence-3 (vpi-3), soj sf-4 reisinger; inaktivirana bakterija mannheimia (pasteurella) haemolytica a1, soj m4/1 - suspenzija za injekciju - imunološki vmp - goveda

NOBIVAC Rabies 克罗地亚 - 克罗地亚文 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

nobivac rabies

intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb, hrvatska - inaktivirani virus bjesnoće, soj pasteur riv - suspenzija za injekciju - imunološki vmp - pasa, mačaka, goveda, konja, ovaca, koza, lisica i tvorova

K-ASSAY®Factor XIII 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

k-assay®factor xiii

biomedica dijagnostika d.o.o. paljetkova 2 10000 zagreb -

K-ASSAY® - Factor XIII Calibrator 克罗地亚 - 克罗地亚文 - HALMED (Agencija za lijekove i medicinske proizvode)

k-assay® - factor xiii calibrator

biomedica dijagnostika d.o.o. paljetkova 2 10000 zagreb -

AVAXIM 160 jedinica/0.5 mL suspenzija za injekciju 波斯尼亚和黑塞哥维那 - 克罗地亚文 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

avaxim 160 jedinica/0.5 ml suspenzija za injekciju

amicus pharma d.o.o. - virus hepatitisa a, inaktivisani, cijeli - suspenzija za injekciju - 160 jedinica/0.5 ml - 1 doza (0,5 ml) suspenzije za injekciju sadrži: 160 jedinica hepatitis a virus (gbm soj), inaktivisan

ACTHIB 10 µg/0.5 mL prašak i rastvarač za rastvor za injekciju u napunjenoj šprici 波斯尼亚和黑塞哥维那 - 克罗地亚文 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

acthib 10 µg/0.5 ml prašak i rastvarač za rastvor za injekciju u napunjenoj šprici

sanofi d.o.o. - hemofilus utjecaj b, prečišćeni antigen konjugovani - prašak i rastvarač za rastvor za injekciju u napunjenoj šprici - 10 µg/0.5 ml - jedna doza od 0,5 ml rastvora za injekciju (rekonstituisana vakcina) sadrži: haemophilus influenzae tip b polisaharid 10µg ((konjugovan na protein tetanusa 1830 µg)

TETAVAX ≥ 40 i.j./0.5 mL suspenzija za injekciju u napunjenom špricu 波斯尼亚和黑塞哥维那 - 克罗地亚文 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

tetavax ≥ 40 i.j./0.5 ml suspenzija za injekciju u napunjenom špricu

amicus pharma d.o.o. - tetanus toksoid - suspenzija za injekciju u napunjenom špricu - ≥ 40 i.j./0.5 ml - 0,5 ml (1 doza) suspenzije za injekciju u napunjenom špricu sadrži: ≥ 40 i.u. toksoid tetanusa